Structured evidence table for Matcha Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Matcha Cognition Randomized Trial | It was once most popular in Japan; however, in recent years, its use in the food industry has increased significantly []. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Matcha Cognition Randomized Trial | Numerous recipes featuring matcha can be found online, and many cafés now offer various flavored versions of this beverage. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Matcha Cognition Randomized Trial | Therefore, the aim of this review is to present and critically evaluate available evidence on the composition of matcha and its documented physiological effects, highlighting both its therapeutic potential and existing research gaps. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Matcha Cognition Randomized Trial | 1 2 3 3 4 5 5 6 7 8 Table 1 9 Camellia sinensis Tea is one of the most popular beverages in the world. | 3 | Sławińska Paulina (2026) | Matcha as a Source of Bioactive Compounds: A Review of Health-Promoting Properties and Potential Applications |
| Matcha Cognition Randomized Trial | Polyphenols strengthen the intestinal barrier and reduce endotoxemia; cocoa bean shell extracts protected against oxysterol‐induced intestinal damage and improved gut microbiota composition in preclinical models (Alia et al. ). | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
| Matcha Cognition Randomized Trial | While many epidemiological studies correlate polyphenol‐rich diets (e.g., Mediterranean diet) with reduced NCCD risk, causality is uncertain due to confounding and measurement error. | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
| Matcha Cognition Randomized Trial | Controlled trials provide more robust evidence but vary widely in doses, formulations, populations and endpoints. | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
| Matcha Cognition Randomized Trial | AMP BBB CNS COMT COSMOS CRP (hs‐CRP) CSF EGCG ENB‐2 (ENB) ENS EVOO FMD GAD‐7 (GAD) GM‐CSF (GM) HDL HOMA‐IR (HOMA) IBS IL IR LDL LPS MCI MMSE NADPH NCCD (NCCDs) PHGG PHQ‐9 (PHQ) PSQI PWV RBANS RCT SCFA SD TNF (TNF‐α) 2024 Non‐communicable chronic diseases account for the majority of morbidity and mortality worldwide. | 3 | Akif Adnan (2026) | Dietary Polyphenols in Non‐Communicable Chronic Diseases: Neuro–Enteric Mechanisms, Multi‐Omics Biomarkers and Translational Opportunities |
Source documents